Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

561 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of the COVID-19 pandemic on the performance of endoscopy in the Tohoku region of Japan.
Iijima K, Matsuhashi T, Shimodaira Y, Mikami T, Yoshimura T, Yanai S, Kudara N, Tsuji T, Matsushita HO, Watanabe H, Koike T, Kato K, Abe Y, Shirahata N, Hikichi T, Katakura K, Kono K, Sakuraba H, Ueno Y, Ohira H, Masamune A, Matsumoto T, Fukuda S; Japan Gastroenterological Endoscopy Society‐Tohoku. Iijima K, et al. Among authors: masamune a. DEN Open. 2023 Jun 1;4(1):e249. doi: 10.1002/deo2.249. eCollection 2024 Apr. DEN Open. 2023. PMID: 37273519 Free PMC article.
Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: Comparison of cases with and without autoimmune pancreatitis in a large cohort.
Naitoh I, Kamisawa T, Tanaka A, Nakazawa T, Kubota K, Takikawa H, Unno M, Masamune A, Kawa S, Nakamura S, Okazaki K; collaborators. Naitoh I, et al. Among authors: masamune a. Dig Liver Dis. 2021 Oct;53(10):1308-1314. doi: 10.1016/j.dld.2021.02.009. Epub 2021 Mar 2. Dig Liver Dis. 2021. PMID: 33664004
Reducing relapse through maintenance steroid treatment can decrease the cancer risk in patients with IgG4-sclerosing cholangitis: Based on a Japanese nationwide study.
Kubota K, Kamisawa T, Nakazawa T, Tanaka A, Naitoh I, Kurita Y, Takikawa H, Unno M, Kawa S, Masamune A, Nakamura S, Okazaki K; Collaborators. Kubota K, et al. Among authors: masamune a. J Gastroenterol Hepatol. 2023 Apr;38(4):556-564. doi: 10.1111/jgh.16066. Epub 2023 Jan 10. J Gastroenterol Hepatol. 2023. PMID: 36403136
Prognostic Benefit of Additional Treatment After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma.
Takahashi S, Hatta W, Watanabe K, Koike T, Shimada T, Hikichi T, Toya Y, Tanaka I, Onozato Y, Hamada K, Fukushi D, Watanabe K, Kayaba S, Ito H, Mikami T, Oikawa T, Takahashi Y, Kondo Y, Yoshimura T, Shiroki T, Nagino K, Hanabata N, Funakubo A, Hirasawa D, Ohira T, Nakamura J, Nakamura T, Nakaya N, Matsumoto T, Fukuda S, Masamune A, Iijima K. Takahashi S, et al. Among authors: masamune a. Dig Dis Sci. 2023 May;68(5):2050-2060. doi: 10.1007/s10620-022-07746-8. Epub 2022 Nov 29. Dig Dis Sci. 2023. PMID: 36445654
Association between perioperative management of antiplatelet agents and risk of post-endoscopic submucosal dissection bleeding in early gastric cancer: analysis of a nationwide multicenter study.
Miura Y, Tsuji Y, Yoshio T, Hatta W, Yabuuchi Y, Hoteya S, Kikuchi D, Tsuji S, Nagami Y, Hikichi T, Kobayashi M, Morita Y, Sumiyoshi T, Iguchi M, Tomida H, Inoue T, Mikami T, Hasatani K, Nishikawa J, Matsumura T, Nebiki H, Nakamatsu D, Ohnita K, Suzuki H, Ueyama H, Hayashi Y, Sugimoto M, Yamaguchi S, Michida T, Yada T, Asahina Y, Narasaka T, Kuribayashi S, Kiyotoki S, Mabe K, Masamune A, Fujishiro M. Miura Y, et al. Among authors: masamune a. Gastrointest Endosc. 2023 May;97(5):889-897. doi: 10.1016/j.gie.2022.12.025. Epub 2023 Jan 11. Gastrointest Endosc. 2023. PMID: 36639059 Free article.
Blue light imaging and linked color imaging as a screening mode for esophageal squamous cell carcinoma in high-risk patients: Multicenter randomized trial.
Ogata Y, Hatta W, Koike T, Takahashi S, Matsuhashi T, Oikawa T, Iwai W, Asonuma S, Okata H, Ohyauchi M, Ito H, Abe Y, Sasaki Y, Kawamura M, Saito M, Uno K, Fujishima F, Nakamura T, Nakaya N, Iijima K, Masamune A. Ogata Y, et al. Among authors: masamune a. Dig Endosc. 2023 Nov;35(7):835-844. doi: 10.1111/den.14538. Epub 2023 Mar 28. Dig Endosc. 2023. PMID: 36802097 Clinical Trial.
Risk factors and pattern of metastatic recurrence after endoscopic resection with additional treatment for esophageal cancer.
Tanaka I, Hatta W, Koike T, Takahashi S, Shimada T, Hikichi T, Toya Y, Onozato Y, Hamada K, Fukushi D, Watanabe K, Kayaba S, Ito H, Tatsuta T, Oikawa T, Takahashi Y, Kondo Y, Yoshimura T, Shiroki T, Nagino K, Hanabata N, Funakubo A, Ohira T, Nakamura J, Nakamura T, Nakaya N, Iijima K, Matsumoto T, Fukuda S, Masamune A, Hirasawa D. Tanaka I, et al. Among authors: masamune a. Dis Esophagus. 2024 Oct 28;37(11):doae048. doi: 10.1093/dote/doae048. Dis Esophagus. 2024. PMID: 38869095
Prevalence and Distribution of Gastric Endoscopy Findings in Non-eosinophilic Esophagitis Eosinophilic Gastrointestinal Diseases: Influence of Atrophic Gastritis.
Mizumoto N, Abe Y, Sasaki Y, Yagi M, Onozato Y, Takahashi Y, Ara N, Nomura E, Kawamura M, Takahashi S, Asonuma S, Shoji M, Kondo Y, Iwai W, Kikuchi R, Saito M, Hatta W, Koike T, Matsuhashi T, Iijima K, Masamune A, Ueno Y. Mizumoto N, et al. Among authors: masamune a. Intern Med. 2024 Sep 11. doi: 10.2169/internalmedicine.4193-24. Online ahead of print. Intern Med. 2024. PMID: 39261065 Free article.
561 results